Viral Infections and Antiviral Therapies
Editat de Amal Kumar Dhara, Amit Kumar Nayaken Limba Engleză Paperback – 11 noi 2022
- Covers emerging and sexually transmitted viruses, including mode of transmission and pathophysiology of viral infections
- Describes antiviral agents and therapeutics for viruses such as rotaviruses, enteroviruses and coronaviruses
- Discusses strategies for the delivery of antiviral agents and vaccinations
Preț: 801.84 lei
Preț vechi: 1039.30 lei
-23% Nou
Puncte Express: 1203
Preț estimativ în valută:
153.48€ • 161.25$ • 128.99£
153.48€ • 161.25$ • 128.99£
Carte tipărită la comandă
Livrare economică 05-19 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323918145
ISBN-10: 032391814X
Pagini: 808
Ilustrații: 120 illustrations (50 in full color)
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 032391814X
Pagini: 808
Ilustrații: 120 illustrations (50 in full color)
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Public țintă
Researchers and Scientists in virology and pharmaceutical sciences; Biomedical and pharmaceutical academia and professionals in the industries; Regulatory scientists in medicine, biomedicine, pharmaceutics, biotechnology, biology, microbiology; Graduate students and post docs with relevant background in virology and pharmacology.Cuprins
Section I: Introduction
1. Introduction to antiviral therapy
Section II: Viral infections and transmission
2. Emerging viral diseases
3. Evolution and transmission of viruses
4. Mode of viral infections and transmissions
5. Transmission and Intervention Dynamics of SARS-CoV-2
6. Sexually transmitted viral infections
7. Testing of viral infections
8. Electron microscopic methods for virus diagnosis
Section III: Antiviral agents and therapeutics
9. Virotherapy
10. Challenges in designing antiviral agents
11. Anti-influenza agents
12. Anti-herpes virus agents
13. Antiretroviral Therapies
14. Rotavirus and anti-rotaviral agents: Trends and advances
15. Current therapeutic strategies and novel antiviral compounds for the treatment of non-polio enteroviruses
16. Antiviral agents against flaviviruses
17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat
18. Herbal drugs to combat viruses
19. Strategies for delivery of antiviral agents
20. Nanovesicles for delivery of antiviral agents
21. Antiviral biomaterials
22. Antiviral biomolecules from marine inhabitantsBalasubramanian
23. Plant polysaccharides as antiviral agents
24. Antiviral peptides against dengue virus
25. mRNA vaccines for COVID-19
26. Immunotherapy as an emerging and promising tool against viral infections
27. Role of nutraceuticals as immunomodulators to combat viruses
Section IV: Others
28. In vitro and in vivo approaches for evaluating antiviral efficacy
29. Clinical trials and regulatory considerations of antiviral agents
30. Future perspectives of antiviral therapy
1. Introduction to antiviral therapy
Section II: Viral infections and transmission
2. Emerging viral diseases
3. Evolution and transmission of viruses
4. Mode of viral infections and transmissions
5. Transmission and Intervention Dynamics of SARS-CoV-2
6. Sexually transmitted viral infections
7. Testing of viral infections
8. Electron microscopic methods for virus diagnosis
Section III: Antiviral agents and therapeutics
9. Virotherapy
10. Challenges in designing antiviral agents
11. Anti-influenza agents
12. Anti-herpes virus agents
13. Antiretroviral Therapies
14. Rotavirus and anti-rotaviral agents: Trends and advances
15. Current therapeutic strategies and novel antiviral compounds for the treatment of non-polio enteroviruses
16. Antiviral agents against flaviviruses
17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat
18. Herbal drugs to combat viruses
19. Strategies for delivery of antiviral agents
20. Nanovesicles for delivery of antiviral agents
21. Antiviral biomaterials
22. Antiviral biomolecules from marine inhabitantsBalasubramanian
23. Plant polysaccharides as antiviral agents
24. Antiviral peptides against dengue virus
25. mRNA vaccines for COVID-19
26. Immunotherapy as an emerging and promising tool against viral infections
27. Role of nutraceuticals as immunomodulators to combat viruses
Section IV: Others
28. In vitro and in vivo approaches for evaluating antiviral efficacy
29. Clinical trials and regulatory considerations of antiviral agents
30. Future perspectives of antiviral therapy